ATE330613T1 - Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis - Google Patents

Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis

Info

Publication number
ATE330613T1
ATE330613T1 AT03000905T AT03000905T ATE330613T1 AT E330613 T1 ATE330613 T1 AT E330613T1 AT 03000905 T AT03000905 T AT 03000905T AT 03000905 T AT03000905 T AT 03000905T AT E330613 T1 ATE330613 T1 AT E330613T1
Authority
AT
Austria
Prior art keywords
prostaglandin
psoriasis
treatment
derivatives
medicament
Prior art date
Application number
AT03000905T
Other languages
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Synphora Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora Ab filed Critical Synphora Ab
Application granted granted Critical
Publication of ATE330613T1 publication Critical patent/ATE330613T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT03000905T 1994-09-21 1995-09-19 Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis ATE330613T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403158A SE9403158D0 (sv) 1994-09-21 1994-09-21 New use of prostaglandins

Publications (1)

Publication Number Publication Date
ATE330613T1 true ATE330613T1 (de) 2006-07-15

Family

ID=20395309

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95933000T ATE236638T1 (de) 1994-09-21 1995-09-19 Neue verwendung von prostaglandinen
AT03000905T ATE330613T1 (de) 1994-09-21 1995-09-19 Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT95933000T ATE236638T1 (de) 1994-09-21 1995-09-19 Neue verwendung von prostaglandinen

Country Status (10)

Country Link
US (1) US6031001A (de)
EP (2) EP1310256B1 (de)
JP (1) JP4044611B2 (de)
AT (2) ATE236638T1 (de)
AU (1) AU705901B2 (de)
CA (1) CA2200480C (de)
DE (2) DE69530303T2 (de)
ES (2) ES2263853T3 (de)
SE (1) SE9403158D0 (de)
WO (1) WO1996009055A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981586A (en) * 1997-05-23 1999-11-09 Pershadsingh; Harrihar A. Methods for treating proliferative and inflammatory skin diseases
SE9702681D0 (sv) * 1997-07-10 1997-07-10 Pharmacia & Upjohn Ab Method and composition for treatment of impotence
FR2773075B1 (fr) * 1997-12-31 2000-05-05 Cird Galderma Utilisation d'activateurs de ppar-gamma en dermatologie
SE9900672D0 (sv) * 1999-02-25 1999-02-25 Synphora Ab Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
WO2000051980A1 (en) 1999-03-05 2000-09-08 The Procter & Gamble Company C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
ATE466577T1 (de) * 2001-05-03 2010-05-15 Cornell Res Foundation Inc Behandlung von krankheiten, die durch hpv verursacht werden
US20050159485A1 (en) * 2002-01-04 2005-07-21 Jost-Price Edward R. Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases
US20060100181A1 (en) * 2002-05-03 2006-05-11 Jost-Price Edward R Combinations for the treatment of inflammatory skin disorders
AU2003221707A1 (en) * 2002-06-14 2003-12-31 Alcon, Inc. Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis
SE0402029D0 (sv) * 2004-08-17 2004-08-17 Synphora Ab Prostaglandin a derivatieves for the treatment of psoriasis
KR100760430B1 (ko) * 2004-12-31 2007-10-04 한미약품 주식회사 당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US9328060B2 (en) 2013-10-18 2016-05-03 East Carolina University J-series prostaglandin-ethanolamides as novel therapeutics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4009282A (en) * 1973-12-17 1977-02-22 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with prostaglandins
DE2460285A1 (de) * 1973-12-25 1975-07-03 Ono Pharmaceutical Co Trans-delta hoch 2-prostaglandinverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4254145A (en) * 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
JPS58216155A (ja) * 1982-06-10 1983-12-15 Ono Pharmaceut Co Ltd 新規なプロスタグランジンｄ類似化合物
ES2053458T3 (es) * 1986-03-13 1994-08-01 Univ Columbia Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
ES2317964T5 (es) * 1988-09-06 2015-02-20 Pfizer Health Ab Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular
CZ277720B6 (en) * 1990-12-29 1993-03-17 Vysoka Skola Chem Tech Pharmaceutic gel containing natural prostaglandins for topic use

Also Published As

Publication number Publication date
SE9403158D0 (sv) 1994-09-21
JPH10505861A (ja) 1998-06-09
DE69530303D1 (de) 2003-05-15
EP0778774B1 (de) 2003-04-09
DE69535081T2 (de) 2007-06-28
AU705901B2 (en) 1999-06-03
AU3581795A (en) 1996-04-09
WO1996009055A1 (en) 1996-03-28
EP1310256A2 (de) 2003-05-14
JP4044611B2 (ja) 2008-02-06
EP1310256B1 (de) 2006-06-21
CA2200480C (en) 2003-03-25
ES2263853T3 (es) 2006-12-16
DE69535081D1 (de) 2006-08-03
EP1310256A3 (de) 2003-06-25
EP0778774A2 (de) 1997-06-18
ATE236638T1 (de) 2003-04-15
CA2200480A1 (en) 1996-03-28
DE69530303T2 (de) 2004-02-12
US6031001A (en) 2000-02-29
ES2194055T3 (es) 2003-11-16

Similar Documents

Publication Publication Date Title
ATE330613T1 (de) Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis
DE69711894D1 (de) Lipoxinverbindungen und deren verwendung zur behandlung der zellenwucherungsstörung
UA19303A (uk) Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу
EP1143950A3 (de) Topisch anwendbare mittel
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69231486D1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung
ATE64270T1 (de) Fungizide verwendung eines cyanopyrrol-derivates.
SE9701144D0 (sv) Novel compounds, their use and preparation
DE69332350D1 (de) Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
NO980317D0 (no) Van-10-x-forbindelser
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
ATE43244T1 (de) Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE69132050D1 (de) Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
DE68916777D1 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
IT1199960B (it) Agenti stimolanti la crescita dei capelli e loro impiego
MD996G2 (ro) Metodă de tratament a cistitei
ATE186048T1 (de) Vitalethin und seine anwendung in zellkultur und therapie
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1310256

Country of ref document: EP

REN Ceased due to non-payment of the annual fee